In This Article:
The United Kingdom market has been experiencing turbulence, with the FTSE 100 index closing lower due to weak trade data from China and a general decline in global economic indicators. Despite these challenges, there are opportunities within small-cap stocks that show potential for growth, particularly those with insider buying activities signaling confidence from within the company.
Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Bytes Technology Group | 23.4x | 5.3x | 17.09% | ★★★★★☆ |
C&C Group | NA | 0.4x | 48.58% | ★★★★★☆ |
Essentra | 799.9x | 1.5x | 48.38% | ★★★★★☆ |
GB Group | NA | 2.9x | 35.66% | ★★★★★☆ |
NWF Group | 8.7x | 0.1x | 35.69% | ★★★★☆☆ |
H&T Group | 7.5x | 0.7x | 12.13% | ★★★★☆☆ |
CVS Group | 22.7x | 1.2x | 40.45% | ★★★★☆☆ |
Norcros | 7.8x | 0.5x | -0.18% | ★★★☆☆☆ |
Foxtons Group | 25.9x | 1.2x | 48.91% | ★★★☆☆☆ |
Watkin Jones | NA | 0.2x | -3.38% | ★★★☆☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Assura
Simply Wall St Value Rating: ★★★★☆☆
Overview: Assura is a UK-based real estate investment trust specializing in the development and management of primary care medical centers, with a market cap of approximately £2.23 billion.
Operations: The company generates revenue primarily from its core segment, reporting £157.8 million in the latest period. Gross profit margins have shown a slight decline from 95.75% to 90.81% over the observed periods, while net income has fluctuated significantly, recently recording a loss of £28.8 million with a net income margin of -18.25%. Operating expenses have remained relatively stable around £14 million in recent periods.
PE: -45.5x
Assura, a small cap in the UK, is showing promising signs of growth with earnings forecasted to grow 41.82% annually. Despite past shareholder dilution, recent insider confidence is evident with purchases made from January to August 2024. The company announced a quarterly dividend of £0.0084 per share payable on October 9, 2024. An interesting move was the acquisition of a private hospital portfolio in August 2024, potentially boosting future revenues despite higher risk funding sources and debt concerns not well covered by operating cash flow.
-
Get an in-depth perspective on Assura's performance by reading our valuation report here.
-
Review our historical performance report to gain insights into Assura's's past performance.
Hammerson
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Hammerson is a real estate investment trust focusing on the development and management of flagship retail destinations in the UK, France, and Ireland with a market cap of approximately £1.23 billion.